LY2828360
CAS: 1231220-79-3
Ref. 3D-GZB22079
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Product Information
LY2828360 is a low-potency cannabinoid receptor agonist that has been shown to antagonize the effects of the endogenous cannabinoid anandamide. This compound has been studied in clinical studies for its potential use as an anti-inflammatory and analgesic agent. LY2828360 is also a CB2 receptor agonist, which has been shown to have potential uses in treating inflammatory diseases such as arthritis, inflammatory bowel disease, or pain models. LY2828360 has also shown efficacy in animal models of colorectal adenocarcinoma and other cancers.
Chemical properties
Technical inquiry about: 3D-GZB22079 LY2828360
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
